Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kim, Y.-J.
Right arrow Articles by Arahata, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y.-J.
Right arrow Articles by Arahata, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 11 1129-1139
© 2001 Oxford University Press

The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression

Yeon-Jeong Kim1,2, Satoru Noguchi1, Yukiko K. Hayashi1,+, Toshifumi Tsukahara1, Takao Shimizu2 and Kiichi Arahata1

1Department of Neuromuscular Research, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan and 2Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0031, Japan

Oculopharyngeal muscular dystrophy (OPMD) is caused by short expansions of the GCG trinucleotide repeat encoding the polyalanine tract of the poly(A)-binding protein 2 (PABP2). PABP2 binds to the growing poly(A) tail, stimulating its extension during the polyadenylation process, and limits the length of the newly synthesized poly(A) tail. Whereas PABP2 is expressed ubiquitously, the clinical and pathological features of OPMD patients are restricted to the skeletal muscle. To elucidate the possible role of PABP2 in skeletal muscle, we established the stable C2 cell lines expressing human PABP2. These stable cell lines showed morphologically enhanced myotube formation accompanied by an increased expression of myogenic factors, MyoD and myogenin. In nuclear run-on assay, the transcription rate of the MyoD gene was significantly increased by PABP2 transfection. We found the N-terminal region of PABP2 was responsible for the up-regulation of these myogenic factors. Furthermore, Ski-interacting protein (SKIP) was isolated as a binding protein for PABP2 using the yeast two-hybrid system. The interaction of PABP2 and SKIP was confirmed by glutathione S-transferase-pulldown assay and immunoprecipitation. Confocal laser scanning showed PABP2 was co-localized with SKIP in nuclear speckles. The reporter assays showed that PABP2 co-operated with SKIP to synergistically activate E-box-mediated transcription through MyoD. Moreover, both PABP2 and SKIP were directly associated with MyoD to form a single complex. These findings suggest that PABP2 and SKIP directly control the expression of muscle-specific genes at the transcription level.

+ To whom correspondence should be addressed. Tel: +81 42 341 2711; Fax: +81 42 346 1742; Email: hayasi_y@ncnp.go.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
H. Catoire, M. Y. Pasco, A. Abu-Baker, S. Holbert, C. Tourette, B. Brais, G. A. Rouleau, J. A. Parker, and C. Neri
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1
Hum. Mol. Genet., July 15, 2008; 17(14): 2108 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Verheesen, A. de Kluijver, S. van Koningsbruggen, M. de Brij, H. J. de Haard, G.-J. B. van Ommen, S. M. van der Maarel, and C. T. Verrips
Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody
Hum. Mol. Genet., January 1, 2006; 15(1): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Q. Wang, D. D. Mosser, and J. Bag
Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells
Hum. Mol. Genet., December 1, 2005; 14(23): 3673 - 3684.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
T. Scheuermann, B. Schulz, A. Blume, E. Wahle, R. Rudolph, and E. Schwarz
Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation
Protein Sci., December 1, 2003; 12(12): 2685 - 2692.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Prathapam, C. Kuhne, and L. Banks
Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activity
Nucleic Acids Res., December 1, 2002; 30(23): 5261 - 5268.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. Gronborg, T. Z. Kristiansen, A. Stensballe, J. S. Andersen, O. Ohara, M. Mann, O. N. Jensen, and A. Pandey
A Mass Spectrometry-based Proteomic Approach for Identification of Serine/Threonine-phosphorylated Proteins by Enrichment with Phospho-specific Antibodies: Identification of a Novel Protein, Frigg, as a Protein Kinase A Substrate
Mol. Cell. Proteomics, July 1, 2002; 1(7): 517 - 527.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
X. Fan, P. Dion, J. Laganiere, B. Brais, and G. A. Rouleau
Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death
Hum. Mol. Genet., October 1, 2001; 10(21): 2341 - 2351.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Prathapam, C. Kuhne, M. Hayman, and L. Banks
Ski interacts with the evolutionarily conserved SNW domain of Skip
Nucleic Acids Res., September 1, 2001; 29(17): 3469 - 3476.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.